UBS Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-295
| Closed | -$1K | – | 8496 |
|
|
2017
Q4 | $1K | Sell |
295
-1,475
| -83% | -$6.04K | ﹤0.01% | 7789 |
|
|
2017
Q3 | $7K | Buy |
1,770
+918
| +108% | +$3.51K | ﹤0.01% | 7117 |
|
|
2017
Q2 | $3K | Sell |
852
-11,970
| -93% | -$47.5K | ﹤0.01% | 7340 |
|
|
2017
Q1 | $53K | Buy |
12,822
+12,576
| +5,112% | +$52.9K | ﹤0.01% | 5491 |
|
|
2016
Q4 | $1K | Sell |
246
-6,971
| -97% | -$45.1K | ﹤0.01% | 7698 |
|
|
2016
Q3 | $71K | Buy |
+7,217
| New | +$51.2K | ﹤0.01% | 5238 |
|
|
2016
Q2 | – | Sell |
-1,331
| Closed | -$10K | – | 8181 |
|
|
2016
Q1 | $10K | Buy |
+1,331
| New | +$10.2K | ﹤0.01% | 6683 |
|
|
2015
Q3 | – | Sell |
-2,785
| Closed | -$62K | – | 8852 |
|
|
2015
Q2 | $62K | Buy |
2,785
+2,635
| +1,757% | +$41.7K | ﹤0.01% | 5821 |
|
|
2015
Q1 | $1K | Sell |
150
-2,758
| -95% | -$27K | ﹤0.01% | 8631 |
|
|
2014
Q4 | $33K | Buy |
+2,908
| New | +$31.6K | ﹤0.01% | 7016 |
|
UBS Group's CASC Position: Q1 2018 in Review
UBS Group sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 295 shares — an estimated $1K sold.
UBS Group first reported a position in CASC in Q4 2014 and held it in 10 quarters. The position peaked at $71K in Q3 2016. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.
- UBS Group reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
- UBS Group sold 295 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $1K.
- UBS Group first reported a position in Cascadian Therapeutics, Inc. in Q4 2014 and held it in 10 quarters.
- UBS Group's Cascadian Therapeutics, Inc. position peaked at $71K in Q3 2016.
- 1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.